Rajkapoor Balasubramanian

About

I am a professor in Pharmacology at KAHE where I have been a faculty member since November 2019. I have been a Professor from 2017-September’2019 in the College of Health Sciences, Mekelle University, Ethiopia, and have been a member of Professional bodies such as APTI, IPS, and IABMS. I received my Ph.D. in Pharmacy (Pharmacology) from The Tamilnadu Dr.M.G.R. Medical University, India & Post-Doctoral Fellowship from Japan in the year 2006 & 2007, respectively. My responsibilities involve Teaching and conducting research in Pharmacology and Toxicology. My areas of research interest are cancer biology, diabetic and toxicological studies in animal models.

Employment

• Karpagam Academy of Higher Education Professor
  2025 - Present
• Mekelle University Professor
  2017 - 2019
• Sebha University Assistant professor
  2009 - 2017
• Dayananda Sagar Institutions Associate/Professor
  2008 - 2009
• VELS Group of Institutions Assistant Professor
  2005 - 2006
• Vinayaka Missions University Lecturer
  2000 - 2005

Education

• International Laboratory of Biochemistry Post doctoral fellow
• Tamil Nadu Dr MGR Medical University B.Pharmacy
• Tamil Nadu Dr MGR Medical University Ph.D
• Tamil Nadu Dr MGR Medical University M.Pharmacy

Projects & Funding

Projects & funding information is unavailable.

Publications (130)

• Optimizing Management of Newly Diagnosed T2DM Mellitus Through Combination Therapy: Efficacy, Safety, and Individualized Care Approaches
  Current Drug Safety 2026 DOI: 10.2174/0115748863463809260715073035
  +Save
• A quercetin derivative from Sarcostemma brevistigma mitigates silica-induced pulmonary injury via regulation of TLR4/NF-κB and Nrf2 signaling pathways
  Toxicon 2026 DOI: 10.1016/j.toxicon.2026.109057
  +Save
• Integrative approaches in snake venom-induced tissue and organ toxicity: Ethnomedicinal and phytochemical strategies as complementary antivenom therapies
  Pharmacological Research - Natural Products 2026 DOI: 10.1016/j.prenap.2026.100597
  +Save
• Cardioprotective Role of 5,7,4′‐Trimethoxy Flavanone Through PI3K/AKT‐Nrf2 Signaling in Mice
  Journal of Biochemical and Molecular Toxicology 2026 DOI: 10.1002/jbt.70821
  +Save
• Exploring the Therapeutic Potential of Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis in Patients wi…
  Hormone and Metabolic Research 2026 DOI: 10.1055/a-2787-1205
  +Save
• Correction: Exploring the Therapeutic Potential of Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis in…
  Hormone and Metabolic Research 2026 DOI: 10.1055/a-2811-1672
  +Save
• An Overview of Evidence-Based Guidelines for Antibiotic Treatment and Prevention in Odontogenic Infections—Current Clinical Perspectives
  Infectious Disorders - Drug Targets 2026 DOI: 10.2174/0118715265464507260406071303
  +Save
• Enhancing Type 2 Diabetes Treatment Through C-Peptide Assessment
  Current Drug Safety 2026 DOI: 10.2174/0115748863422954251022101427
  +Save
• Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Epidemiology, Mechanisms, Diagnosis, Prevention, and Future Perspectives
  SN Comprehensive Clinical Medicine 2026 DOI: 10.1007/S42399-026-02540-3
  +Save
• In Vitro Antioxidant and Antidiabetic Potential of Ethanolic Leaf Extract of Glycosmis pentaphylla (Retz.) DC
  2026 DOI: 10.2139/ssrn.6169979
  +Save